SSS

STAR COMBO PHARMA LIMITED

No trades
See on Supercharts
Market capitalization
‪16.20 M‬AUD
‪−4.00 M‬AUD
‪24.70 M‬AUD
‪30.52 M‬
Beta (1Y)
0.33

About STAR COMBO PHARMA LIMITED

Headquarters
Smithfield
Founded
2016
ISIN
AU0000004798
FIGI
BBG00K4LGNJ6
Star Combo Pharma Ltd. engages in the manufacture and distribution of vitamis, dietary supplements, and skincare products. It operates through the segments: Star Combo and Austoyou. The Star Combo engages in developing, manufacturing, marketing and sale of natural health supplements and ski8n care products. The Austoyou segment offers product lines to Chinese health product consumers. The company was founded by Star Zhang in 2004 and is headquartered in Smithfield, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of S66 is 0.120 AUD — it has increased by 4.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange STAR COMBO PHARMA LIMITED stocks are traded under the ticker S66.
S66 stock is 4.17% volatile and has beta coefficient of 0.33. Check out the list of the most volatile stocks — is STAR COMBO PHARMA LIMITED there?
Yes, you can track STAR COMBO PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
S66 stock has risen by 4.35% compared to the previous week, the month change is a 17.24% fall, over the last year STAR COMBO PHARMA LIMITED has showed a 9.09% increase.
S66 net income for the last quarter is ‪125.71 K‬ AUD, while the quarter before that showed ‪359.45 K‬ AUD of net income which accounts for −65.03% change. Track more STAR COMBO PHARMA LIMITED financial stats to get the full picture.
Today STAR COMBO PHARMA LIMITED has the market capitalization of ‪16.20 M‬, it has increased by 4.35% over the last week.
No, S66 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, S66 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STAR COMBO PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
S66 reached its all-time high on May 22, 2018 with the price of 2.030 AUD, and its all-time low was 0.090 AUD and was reached on Jul 5, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STAR COMBO PHARMA LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STAR COMBO PHARMA LIMITED stock shows the sell signal. See more of STAR COMBO PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STAR COMBO PHARMA LIMITED EBITDA is ‪1.20 M‬ AUD, and current EBITDA margin is 6.89%. See more stats in STAR COMBO PHARMA LIMITED financial statements.